Clinical Trial Update: Study of the Usefulness of the Probiotic 'Lactobacillus Reuteri' in the Therapy of Quadruple Eradication of Helicobacter Pylori Infection in Usual Clinical Practice. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating the usefulness of the probiotic Lactobacillus reuteri as part of quadruple therapy for Helicobacter pylori infection in u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• Lactobacillus reuteri (Lactobacillus reuteri)

Snippet

Sponsor: Dr. Luis Fernandez | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: UNKNOWN